NightHawk Biosciences, Inc. – AMEX:NHWK
NightHawk Biosciences stock price monthly change
NightHawk Biosciences stock price quarterly change
NightHawk Biosciences stock price yearly change
NightHawk Biosciences key metrics
Market Cap | 10.78M |
Enterprise value | 20.67M |
P/E | -0.47 |
EV/Sales | 3.11 |
EV/EBITDA | -0.38 |
Price/Sales | 2.96 |
Price/Book | 0.26 |
PEG ratio | 0.02 |
EPS | 4252.29 |
Revenue | 6.37B |
EBITDA | -39.14M |
Income | 110.43B |
Revenue Q/Q | -87.90% |
Revenue Y/Y | 92923.38% |
Profit margin | -928.49% |
Oper. margin | -946.03% |
Gross margin | -0.27% |
EBIT margin | -946.03% |
EBITDA margin | -0.61% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNightHawk Biosciences stock price history
NightHawk Biosciences stock forecast
NightHawk Biosciences financial statements
| Dec 2022 | 6.37B | -12.31M | -0.19% |
|---|---|---|---|
| Mar 2023 | 765.9K | 110.47B | 14424351.07% |
| Jun 2023 | 657.77K | -13.89M | -2111.96% |
| Sep 2023 | 723.12K | -13.13M | -1816.07% |
| 2025 | 35.1M | -16.6M | -47.29% |
|---|
Analysts Price target
Financials & Ratios estimates
| Dec 2022 | 104396912 | 31.96M | 30.61% |
|---|---|---|---|
| Mar 2023 | 91517951 | 31.17M | 34.07% |
| Jun 2023 | 80184407 | 33.11M | 41.3% |
| Sep 2023 | 69915144 | 36.46M | 52.16% |
| Dec 2022 | -7.84M | 7.36M | -4.76M |
|---|---|---|---|
| Mar 2023 | -13.79M | 13.48M | -298.52K |
| Jun 2023 | -8.20M | 8.83M | -2.61M |
| Sep 2023 | -13.67M | 7.81M | 164.61K |
NightHawk Biosciences alternative data
| Aug 2023 | 77 |
|---|---|
| Sep 2023 | 77 |
| Oct 2023 | 77 |
| Nov 2023 | 77 |
| Dec 2023 | 77 |
| Jan 2024 | 77 |
| Feb 2024 | 77 |
| Mar 2024 | 77 |
| Apr 2024 | 77 |
| May 2024 | 77 |
| Jun 2024 | 77 |
| Jul 2024 | 77 |
NightHawk Biosciences other data
| Period | Buy | Sel |
|---|---|---|
| Nov 2020 | 0 | 103304 |
| May 2021 | 0 | 35000 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | PRENDERGAST JOHN K A director | Common Stock | 35,000 | $5.87 | $205,310 | ||
Sale | SMITH EDWARD B III director | Common Stock | 103,304 | $1.03 | $106,403 | ||
Option | OSTRANDER WILLIAM L. officer: VP Finan.. | Employee Stock Option (right to buy) | 15,625 | $0.52 | $8,125 | ||
Option | OSTRANDER WILLIAM L. officer: VP Finan.. | Common Stock | 15,625 | $0.52 | $8,125 |
-
When is NightHawk Biosciences's next earnings date?
Unfortunately, NightHawk Biosciences's (NHWK) next earnings date is currently unknown.
-
Does NightHawk Biosciences pay dividends?
No, NightHawk Biosciences does not pay dividends.
-
How much money does NightHawk Biosciences make?
NightHawk Biosciences has a market capitalization of 10.78M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 183.08% to 5.98M US dollars.
-
What is NightHawk Biosciences's stock symbol?
NightHawk Biosciences, Inc. is traded on the AMEX under the ticker symbol "NHWK".
-
What is NightHawk Biosciences's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of NightHawk Biosciences?
Shares of NightHawk Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does NightHawk Biosciences have?
As Jul 2024, NightHawk Biosciences employs 77 workers.
-
When NightHawk Biosciences went public?
NightHawk Biosciences, Inc. is publicly traded company for more then 12 years since IPO on 24 Jul 2013.
-
What is NightHawk Biosciences's official website?
The official website for NightHawk Biosciences is nighthawkbio.com.
-
Where are NightHawk Biosciences's headquarters?
NightHawk Biosciences is headquartered at 627 Davis Drive, Morrisville, NC.
-
How can i contact NightHawk Biosciences?
NightHawk Biosciences's mailing address is 627 Davis Drive, Morrisville, NC and company can be reached via phone at +91 92407133.
NightHawk Biosciences company profile:
NightHawk Biosciences, Inc.
nighthawkbio.comAMEX
77
Biotechnology
Healthcare
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. The company develops HS-110, which has completed enrollment in a Phase II clinical trial to treat patients with advanced non-small cell lung cancer; and HS-130 that is in Phase I clinical trial for the treatment of advanced solid tumors. Its products also include PTX-35, a novel T-cell co-stimulator agonist antibody targeting DR3/TNFRSF25 that is in Phase I clinical trial; DR3/TNFRSF25 for various immunotherapy approaches; and COVID-19 vaccine, which is in preclinical stage. The company has a collaboration with Dr. James Shapiro at University of Alberta to manufacture surrogate mouse version of PTX-35. The company was formerly known as Heat Biologics, Inc. and changed its name to NightHawk Biosciences, Inc. in May 2022. NightHawk Biosciences, Inc. was incorporated in 2008 and is headquartered in Morrisville, North Carolina.
Morrisville, NC 27560
CIK: 0001476963
ISIN: US42237K4094
CUSIP: 42237K409
